Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 138
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Field Notes #1: Psychiatrists, Regulators, Ibogaine, and the Race for Psilocybin Approval
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health...
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort...
First Patient Dosed in Small Pharma’s Drug Interaction Study
Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement
Revive Therapeutics Ltd. Expands Life Offering to Quebec
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT
Israeli Based Biotech Company Clearmind Medicine Inc’s CEO, Dr. Adi Zuloff-Shani,...
Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics,...
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE...
PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert...
Load more